• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.

作者信息

Siddiqi Hasan K, Mehra Mandeep R

机构信息

Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.

DOI:10.1016/j.healun.2020.03.012
PMID:32362390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118652/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8960/7118652/abd8dd8a406e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8960/7118652/abd8dd8a406e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8960/7118652/abd8dd8a406e/gr1_lrg.jpg

相似文献

1
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
2
ERCP during the pandemic of COVID-19 in Wuhan, China.中国武汉新冠疫情期间的内镜逆行胰胆管造影术
Gastrointest Endosc. 2020 Aug;92(2):448-454. doi: 10.1016/j.gie.2020.04.022. Epub 2020 Apr 16.
3
The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges.中国的新型冠状病毒（严重急性呼吸综合征冠状病毒2）感染：预防、控制与挑战
Intensive Care Med. 2020 Apr;46(4):591-593. doi: 10.1007/s00134-020-05977-9. Epub 2020 Mar 2.
4
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.中国无症状旅行者引发的大规模新冠病毒疫情。
Emerg Infect Dis. 2020 Dec;26(12):3106. doi: 10.3201/eid2612.203437.
5
Heart retransplantation following COVID-19 illness in a heart transplant recipient.一名心脏移植受者在感染 COVID-19 后的心脏再次移植
J Heart Lung Transplant. 2020 Sep;39(9):983-985. doi: 10.1016/j.healun.2020.06.026. Epub 2020 Jul 7.
6
A hundred days into the coronavirus disease (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）疫情爆发一百天之际。
Euro Surveill. 2020 Apr;25(14). doi: 10.2807/1560-7917.ES.2020.25.14.2000550.
7
Letter to the editor: Headline stress disorder caused by Netnews during the outbreak of COVID-19.致编辑的信：COVID-19疫情期间网络新闻引发的标题应激障碍
Health Expect. 2020 Apr;23(2):259-260. doi: 10.1111/hex.13055.
8
Re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748-54.回复：朱兰、龚念乔、刘斌等。《2019冠状病毒病肺炎在免疫抑制的肾移植受者中的情况：中国武汉10例确诊病例总结》。《欧洲泌尿外科杂志》2020年；77卷：748 - 54页。
Eur Urol. 2020 Oct;78(4):e158. doi: 10.1016/j.eururo.2020.06.058. Epub 2020 Jul 4.
9
As We Went to Press: COVID-19 Continues to Spread.见报时：COVID-19 持续传播。
Am J Nurs. 2020 Apr;120(4):15. doi: 10.1097/01.NAJ.0000659956.26994.75.
10
The role of masks and respirator protection against SARS-CoV-2.口罩和呼吸器对严重急性呼吸综合征冠状病毒2的防护作用。
Infect Control Hosp Epidemiol. 2020 Jun;41(6):746-747. doi: 10.1017/ice.2020.83.

引用本文的文献

1
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?长期新冠症状和新冠疫苗副作用是否具有共同的病理生理特征和生化途径？
Int J Mol Sci. 2025 Aug 15;26(16):7879. doi: 10.3390/ijms26167879.
2
COVID-19 Organ Injury Pathology and D-Dimer Expression Patterns: A Retrospective Analysis.新型冠状病毒肺炎器官损伤病理学与D-二聚体表达模式：一项回顾性分析
Diagnostics (Basel). 2025 Jul 24;15(15):1860. doi: 10.3390/diagnostics15151860.
3
Effectiveness of remdesivir for hospitalized COVID-19 patients depending on the severity of respiratory status: a multicenter retrospective study in Japan.

本文引用的文献

1
First cases of COVID-19 in heart transplantation from China.中国心脏移植中首例新冠病毒病病例。
J Heart Lung Transplant. 2020 May;39(5):496-497. doi: 10.1016/j.healun.2020.03.006. Epub 2020 Mar 17.
2
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report.2019 年冠状病毒病疫情期间武汉心脏移植受者的流行病学和临床特征：描述性调查研究报告。
J Heart Lung Transplant. 2020 May;39(5):412-417. doi: 10.1016/j.healun.2020.03.008. Epub 2020 Mar 25.
3
COVID-19: Yet another coronavirus challenge in transplantation.
瑞德西韦对不同呼吸状态严重程度的住院COVID-19患者的疗效：日本一项多中心回顾性研究
BMC Infect Dis. 2025 Aug 13;25(1):1016. doi: 10.1186/s12879-025-11345-z.
4
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways.经鼻腔吸入抗病毒微粒粉末以靶向治疗上呼吸道早期感染。
Drug Deliv Transl Res. 2025 Jul 15. doi: 10.1007/s13346-025-01916-7.
5
Real-World Effectiveness of Nirmatrelvir/Ritonavir in Hospitalized Older Adults with Severe Omicron COVID-19: A Retrospective Cohort Study from China.奈玛特韦/利托那韦对住院的重症奥密克戎新冠病毒肺炎老年患者的真实世界疗效：一项来自中国的回顾性队列研究
Infect Drug Resist. 2025 Jun 7;18:2901-2909. doi: 10.2147/IDR.S518205. eCollection 2025.
6
Protein disulphide isomerase A4 as a potential biomarker for coronavirus disease 2019: Correlation with cytokine profiles and disease progression.蛋白质二硫键异构酶A4作为2019冠状病毒病的潜在生物标志物：与细胞因子谱及疾病进展的相关性
Virulence. 2025 Dec;16(1):2508815. doi: 10.1080/21505594.2025.2508815. Epub 2025 May 26.
7
LBP and iFABP mismatch in the evaluation of intestinal barrier dysfunction due to SARS-CoV-2 infection.在评估由SARS-CoV-2感染引起的肠道屏障功能障碍中LBP与iFABP的不匹配
Clinics (Sao Paulo). 2025 Apr 23;80:100642. doi: 10.1016/j.clinsp.2025.100642. eCollection 2025.
8
Clinical and molecular characteristics of Staphylococcus aureus isolates from patients with COVID-19 in Southwest China.中国西南部新冠肺炎患者金黄色葡萄球菌分离株的临床和分子特征
BMC Infect Dis. 2025 Apr 17;25(1):546. doi: 10.1186/s12879-025-10868-9.
9
Differences in the inflammatory response and outcome among hospitalized patients during different waves of the COVID-19 pandemic.新冠疫情不同波次期间住院患者炎症反应及预后的差异。
Front Immunol. 2025 Mar 27;16:1545181. doi: 10.3389/fimmu.2025.1545181. eCollection 2025.
10
Early lymphopenia as a predictor of COVID-19 outcomes: A multicenter cohort study.早期淋巴细胞减少作为COVID-19预后的预测指标：一项多中心队列研究。
Acute Med Surg. 2025 Mar 21;12(1):e70044. doi: 10.1002/ams2.70044. eCollection 2025 Jan-Dec.
新冠病毒肺炎：移植领域面临的又一冠状病毒挑战。
J Heart Lung Transplant. 2020 May;39(5):408-409. doi: 10.1016/j.healun.2020.03.007. Epub 2020 Mar 14.
4
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
5
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
6
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
7
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.
8
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
9
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
10
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.新型冠状病毒受体识别：基于 SARS 冠状病毒长达十年结构研究的分析。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.00127-20.